Keyphrases
American Urological Association
21%
Androgen Deprivation Therapy
11%
Assessment Development
24%
Benign Prostatic Hyperplasia
62%
Bladder Cancer
14%
Certainty of Evidence
18%
Clinical Practice Guidelines
28%
Clinically Significant Prostate Cancer
28%
Cochrane
12%
Cochrane Review
46%
Confidence Interval
84%
Erectile Function
12%
Evaluation Assessment
24%
Evidence-based
17%
Evidence-based Clinical Practice
15%
Evidence-based Medicine
30%
Grading of Recommendations
24%
Guideline Development
15%
Literature Search
12%
Localized Prostate Cancer
16%
Lower Urinary Tract Symptoms
56%
MEDLINE
15%
Meta-analysis
32%
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
21%
Methodological Quality
21%
Monotherapy
12%
Non-muscle Invasive Bladder Cancer (NMIBC)
12%
Patient Care
17%
Prostate
12%
Prostate Cancer
67%
Prostate-specific Antigen
16%
Prostatic Arterial Embolization
14%
Quality of Life
16%
Radical Cystectomy
16%
Radical Prostatectomy
16%
Radical Retropubic Prostatectomy
55%
Randomized Controlled Trial
68%
Randomized Trial
13%
Renal Cell Carcinoma
14%
Reporting Quality
21%
Review Authors
13%
Risk Ratio
32%
Robot-assisted Laparoscopic Radical Prostatectomy
31%
Surgical Intervention
14%
Systematic Meta-analysis
23%
Transurethral Resection of Prostate
12%
Ureteroscopy
12%
Urologists
42%
Urology
62%
Urology Practice
11%
Medicine and Dentistry
Adverse Event
26%
Arterial Embolization
13%
Biopsy Technique
15%
Bladder
8%
Bladder Cancer
17%
Bleeding
9%
Body Mass Index
12%
Clear Cell Renal Cell Carcinoma
12%
Clinician
10%
Continence
20%
Cystectomy
13%
Dendritic Cell
11%
Diagnostic Accuracy
10%
Diagnostic Test
8%
Disease
24%
Diseases
12%
Evidence-Based Medicine
27%
Gleason Score
8%
Health Care
11%
Health Care Cost
11%
Injury
8%
Kidney Stone
27%
Kidney Tumour
17%
Lower Urinary Tract Symptom
30%
Malignant Neoplasm
18%
Meta-Analysis
18%
Myeloid Cell
8%
Neoplasm
26%
Observational Study
16%
Patient Care
8%
Prostate Cancer
100%
Prostate Hypertrophy
33%
Prostate Specific Antigen
17%
Prostatectomy
79%
Quality of Life
39%
Radical Retropubic Prostatectomy
11%
Randomized Controlled Trial
49%
Recurrent Disease
8%
Robot-Assisted Prostatectomy
17%
Subgroup Analysis
10%
Surgery
26%
Surgical Margin
7%
Systematic Review
72%
T-Cell Response
7%
Transurethral Resection
17%
Ureter Stone
9%
Ureteroscopy
10%
Urinary System
21%
Urologist
30%
Urology
55%